Dose Response Study of Patients With Erythematous Rosacea

Clinical trial NCT01186068 · COMPLETED

Trial details

NCT number: NCT01186068
Sponsor: Vicept Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Erythematous (Type One) Rosacea

Start date: 2010-08-01
Enrollment: 175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.